RecruitingDepression MildDepression Moderate
Treating Major Depression With Yoga Mono-therapy
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The goal of this single-center, single-blind, randomized, controlled, parallel group, interventional trial is to evaluate antidepressant efficacy of yoga monotherapy of 12-weeks duration in 180 adults meeting diagnostic criteria for mild-to-moderate major depression at the Zuckerberg San Francisco General Hospital. Researchers will compare the yoga interventions to an education control intervention on holistic healthcare.
Sponsor: University of California, San Francisco
You may qualify if…
- ✓ 18 years of age or older
- ✓ Able to give voluntary, informed consent
- ✓ English-speaking
- ✓ Diagnosis of clinical depression
You may not qualify if…
- ✕ Current use of antidepressant medication
- ✕ Current engagement in psychotherapy
- ✕ Current pregnancy
- ✕ Significant medical issues interfering with yoga practice
Where it's recruiting
California
San Francisco
Source: ClinicalTrials.gov · NCT06091527 · last updated 2025-11-06